Regeneron Pharmaceuticals, Inc. v. Novartis Pharma AG

Case Number:

IPR2021-00816

Case Type:

IPR

Status:

Trial Instituted

Petitioner:

Regeneron Pharmaceuticals, Inc.

Patent Owner:

Novartis Pharma AG

Patent Number:

9220631

Tech Center:

3700

1. Filed: April 16, 2021 00:00

   Coverage

   1. October 27, 2021

      Regeneron Gets PTAB To Review Syringe Patent On 2nd Go

      Regeneron has convinced the Patent Trial and Appeal Board to review claims in a Novartis patent that covers a type of syringe used in eye injections after the Swiss drug giant dropped a related case against Regeneron at the U.S. International Trade Commission.

   ---

   Stay ahead of the curve

   In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

   
   

   • Search PTAB cases and full-text documents.
   • Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
   • Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!

   TRY LAW360 FREE FOR SEVEN DAYS

   View the PTAB case documents

   Already a subscriber? Click here to login